Population-dependent contribution of the major histocompatibility complex region to schizophrenia susceptibility

Schizophrenia Research

Volumn 168, Issue 1-2, 2015, Pages 444-449

  Yamada, Kazuo ^a   Hattori, Eiji ^a   Iwayama, Yoshimi ^a   Toyota, Tomoko ^a   Iwata, Yasuhide ^b   Suzuki, Katsuaki ^b   Kikuchi, Mitsuru ^c   Hashimoto, Tasuku ^d   Kanahara, Nobuhisa ^d   Mori, Norio ^b   Yoshikawa, Takeo ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Association study; Major histocompatibility complex; MutS homolog 5 suppressor APC domain containing 1; Schizophrenia; Single nucleotide polymorphism; Solute carrier family 44 member 4

Indexed keywords

HLA ANTIGEN; CARRIER PROTEIN; CHOLINE TRANSPORTER-LIKE PROTEIN 4, HUMAN;

ADULT; ARTICLE; BRAIN REGION; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE; GENE EXPRESSION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC SELECTION; GENOTYPE; HUMAN; HUMAN TISSUE; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINOR HISTOCOMPATIBILITY COMPLEX; MSH5 SAPCD1 GENE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; JAPAN; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

EID: 84942374191     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.08.018     Document Type: Article

References (30)

1. Altman D.G., Bland J.M. How to obtain the confidence interval from a P value. BMJ 2011, 343:d2090.
2. Balan S., Iwayama Y., Yamada K., Toyota T., Ohnishi T., Toyoshima M., Shimamoto C., Ide M., Iwata Y., Suzuki K., Kikuchi M., Hashimoto T., Kanahara N., Yoshikawa T., Maekawa M. Sequencing and expression analyses of the synaptic lipid raft adapter gene PAG1 in schizophrenia. J. Neural Transm. 2014, 122(3):477-485.
3. Carlson C.S., Eberle M.A., Rieder M.J., Yi Q., Kruglyak L., Nickerson D.A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 2004, 74(1):106-120.
4. Clark N., Wu X., Her C. MutS homologues hMSH4 and hMSH5: genetic variations, functions, and implications in human diseases. Curr. Genomics 2013, 14(2):81-90.
5. de Bakker P.I., Raychaudhuri S. Interrogating the major histocompatibility complex with high-throughput genomics. Hum. Mol. Genet. 2012, 21(R1):R29-R36.
6. de Bakker P.I., McVean G., Sabeti P.C., Miretti M.M., Green T., Marchini J., Ke X., Monsuur A.J., Whittaker P., Delgado M., Morrison J., Richardson A., Walsh E.C., Gao X., Galver L., Hart J., Hafler D.A., Pericak-Vance M., Todd J.A., Daly M.J., Trowsdale J., Wijmenga C., Vyse T.J., Beck S., Murray S.S., Carrington M., Gregory S., Deloukas P., Rioux J.D. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 2006, 38(10):1166-1172.
7. Erlich H.A., Valdes A.M., McDevitt S.L., Simen B.B., Blake L.A., McGowan K.R., Todd J.A., Rich S.S., Noble J.A., Type 1 Diabetes Genetics Consortium (T1DGC) Next generation sequencing reveals the association of DRB302:02 with type 1 diabetes. Diabetes 2013, 62(7):2618-2622.
8. Hattori E., Toyota T., Ishitsuka Y., Iwayama Y., Yamada K., Ujike H., Morita Y., Kodama M., Nakata K., Minabe Y., Nakamura K., Iwata Y., Takei N., Mori N., Naitoh H., Yamanouchi Y., Iwata N., Ozaki N., Kato T., Nishikawa T., Kashiwa A., Suzuki M., Shioe K., Shinohara M., Hirano M., Nanko S., Akahane A., Ueno M., Kaneko N., Watanabe Y., Someya T., Hashimoto K., Iyo M., Itokawa M., Arai M., Nankai M., Inada T., Yoshida S., Kunugi H., Nakamura M., Iijima Y., Okazaki Y., Higuchi T., Yoshikawa T. Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B(8):1110-1117.
9. Ikeda M., Aleksic B., Kinoshita Y., Okochi T., Kawashima K., Kushima I., Ito Y., Nakamura Y., Kishi T., Okumura T., Fukuo Y., Williams H.J., Hamshere M.L., Ivanov D., Inada T., Suzuki M., Hashimoto R., Ujike H., Takeda M., Craddock N., Kaibuchi K., Owen M.J., Ozaki N., O'Donovan M.C., Iwata N. Genome-wide association study of schizophrenia in a Japanese population. Biol. Psychiatry 2011, 69(5):472-478.
10. Ikeda M., Aleksic B., Yamada K., Iwayama-Shigeno Y., Matsuo K., Numata S., Watanabe Y., Ohnuma T., Kaneko T., Fukuo Y., Okochi T., Toyota T., Hattori E., Shimodera S., Itakura M., Nunokawa A., Shibata N., Tanaka H., Yoneda H., Arai H., Someya T., Ohmori T., Yoshikawa T., Ozaki N., Iwata N. Genetic evidence for association between NOTCH4 and schizophrenia supported by a GWAS follow-up study in a Japanese population. Mol. Psychiatry 2013, 18(6):636-638.
11. Inazu M. Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy. Biopharm. Drug Dispos. 2014, 35(8):431-449.
12. International Schizophrenia, C., Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460(7256):748-752.
13. Maekawa M., Yamada K., Toyoshima M., Ohnishi T., Iwayama Y., Shimamoto C., Toyota T., Nozaki Y., Balan S., Matsuzaki H., Iwata Y., Suzuki K., Miyashita M., Kikuchi M., Kato M., Okada Y., Akamatsu W., Mori N., Owada Y., Itokawa M., Okano H., Yoshikawa T. Utility of scalp hair follicles as a novel source of biomarker genes for psychiatric illnesses. Biol. Psychiatry 2014, 78(2):116-125.
14. Magi R., Morris A.P. GWAMA: software for genome-wide association meta-analysis. BMC Bioinf. 2010, 11:288.
15. Müller N. Immunology of schizophrenia. Neuroimmunomodulation 2014, 21(2-3):109-116.
16. Rakshambikai R., Srinivasan N., Nishant K.T. Structural insights into Saccharomyces cerevisiae Msh4-Msh5 complex function using homology modeling. PLoS One 2013, 8(11).
17. Schizophrenia Working Group of the Psychiatric Genomics, C. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511(7510):421-427.
18. Sekine H., Ferreira R.C., Pan-Hammarstrom Q., Graham R.R., Ziemba B., de Vries S.S., Liu J., Hippen K., Koeuth T., Ortmann W., Iwahori A., Elliott M.K., Offer S., Skon C., Du L., Novitzke J., Lee A.T., Zhao N., Tompkins J.D., Altshuler D., Gregersen P.K., Cunningham-Rundles C., Harris R.S., Her C., Nelson D.L., Hammarstrom L., Gilkeson G.S., Behrens T.W. Role for Msh5 in the regulation of Ig class switch recombination. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(17):7193-7198.
19. Seyrantepe V., Poupetova H., Froissart R., Zabot M.T., Maire I., Pshezhetsky A.V. Molecular pathology of NEU1 gene in sialidosis. Hum. Mutat. 2003, 22(5):343-352.
20. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460(7256):753-757.
21. Song G.G., Choi S.J., Ji J.D., Lee Y.H. Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis. Mol. Biol. Rep. 2013, 40(3):2557-2564.
22. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietilainen O.P., Mors O., Mortensen P.B., Sigurdsson E., Gustafsson O., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Suvisaari J., Lonnqvist J., Paunio T., Borglum A.D., Hartmann A., Fink-Jensen A., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Bottcher Y., Olesen J., Breuer R., Moller H.J., Giegling I., Rasmussen H.B., Timm S., Mattheisen M., Bitter I., Rethelyi J.M., Magnusdottir B.B., Sigmundsson T., Olason P., Masson G., Gulcher J.R., Haraldsson M., Fossdal R., Thorgeirsson T.E., Thorsteinsdottir U., Ruggeri M., Tosato S., Franke B., Strengman E., Kiemeney L.A., Genetic, R., Outcome in, P., Melle I., Djurovic S., Abramova L., Kaleda V., Sanjuan J., de Frutos R., Bramon E., Vassos E., Fraser G., Ettinger U., Picchioni M., Walker N., Toulopoulou T., Need A.C., Ge D., Yoon J.L., Shianna K.V., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Carracedo A., Arango C., Costas J., Jonsson E.G., Terenius L., Agartz I., Petursson H., Nothen M.M., Rietschel M., Matthews P.M., Muglia P., Peltonen L., St Clair D., Goldstein D.B., Stefansson K., Collier D.A. Common variants conferring risk of schizophrenia. Nature 2009, 460(7256):744-747.
23. Uhl J., Penzel R., Sergi C., Kopitz J., Otto H.F., Cantz M. Identification of a CTL4/Neu1 fusion transcript in a sialidosis patient. FEBS Lett. 2002, 521(1-3):19-23.
24. Viatte S., Plant D., Han B., Fu B., Yarwood A., Thomson W., Symmons D.P., Worthington J., Young A., Hyrich K.L., Morgan A.W., Wilson A.G., Isaacs J.D., Raychaudhuri S., Barton A. Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response. JAMA 2015, 313(16):1645-1656.
25. Wang Z., Wei J., Zhang X., Guo Y., Xu Q., Liu S., Shi J., Yu Y., Ju G., Li Y., Shen Y. A review and re-evaluation of an association between the NOTCH4 locus and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B(8):902-906.
26. Wright P., Nimgaonkar V.L., Donaldson P.T., Murray R.M. Schizophrenia and HLA: a review. Schizophr. Res. 2001, 47(1):1-12.
27. Yamada K., Nakamura K., Minabe Y., Iwayama-Shigeno Y., Takao H., Toyota T., Hattori E., Takei N., Sekine Y., Suzuki K., Iwata Y., Miyoshi K., Honda A., Baba K., Katayama T., Tohyama M., Mori N., Yoshikawa T. Association analysis of FEZ1 variants with schizophrenia in Japanese cohorts. Biol. Psychiatry 2004, 56(9):683-690.
28. Yamada K., Hattori E., Iwayama Y., Ohnishi T., Ohba H., Toyota T., Takao H., Minabe Y., Nakatani N., Higuchi T., Detera-Wadleigh S.D., Yoshikawa T. Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biol. Psychiatry 2006, 60(2):192-201.
29. Yamada K., Iwayama Y., Hattori E., Iwamoto K., Toyota T., Ohnishi T., Ohba H., Maekawa M., Kato K., Yoshikawa T. Genome-wide association study of schizophrenia. PLoS One 2011, 6(6):e20468.
30. Zhang Y., Lu T., Yan H., Ruan Y., Wang L., Zhang D., Yue W., Lu L. Replication of association between schizophrenia and chromosome 6p21-6p22.1 polymorphisms in Chinese Han population. PLoS One 2013, 8(2):e56732.